The fabrication of hybrid micelles with enhanced permeability for drug delivery via a diethoxymethylsilyl-based crosslinking strategy

A novel reducible silica monomer, DESSPMA with diethoxysilyl groups for in situ crosslinking to give a lower crosslinking density and greater permeability than the triethoxysilyl-based TESSPMA was developed to realize enhanced therapeutic efficiency.